News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Was a Drop in CRISPR Firms’ Stock Warranted?
Claire Asher | Jun 7, 2017
A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.
Another CRISPR Biotech Goes Public
Bob Grant | Sep 12, 2016
CRISPR Therapeutics, the company started by a pioneer of the gene editing technology, plans to raise $90 million from an initial public offering.
Biotech Stocks Take a Hit
Kerry Grens | Sep 30, 2015
Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.
Biotech Terminates IPO
Jyoti Madhusoodanan | Aug 15, 2014
The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading.
New Year’s Biotech IPO Boom?
Tracy Vence | Feb 3, 2014
January was a profitable month for biotech companies going public, Burrill & Company says.
Week in Review: August 26–30
Tracy Vence | Aug 30, 2013
New model for neurodevelopment; more biotechs going public; how a virus jumped from mammals to birds; statin side effect linked to genetic variant
Biotech IPOs Surge
Kerry Grens | Aug 23, 2013
Beth Marie Mole | Feb 4, 2013
Using evolutionary animal behavior theories, researchers find daytime stock traders’ strategies are maladapted.
Betting on Biotech
Scott Veggeberg | Apr 5, 1993
Despite chill winds on Wall Street, investors continue to place bets on fledgling biotechnology companies.